Advertisement
Advertisement
U.S. markets open in 10 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
32.69+1.76 (+5.69%)
At close: 04:00PM EST
32.00 -0.69 (-2.11%)
Pre-Market: 09:11AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close30.93
Open30.81
Bid30.67 x 800
Ask35.31 x 900
Day's Range30.75 - 32.91
52 Week Range12.80 - 50.54
Volume543,723
Avg. Volume2,034,896
Market Cap1.56B
Beta (5Y Monthly)2.22
PE Ratio (TTM)N/A
EPS (TTM)-2.43
Earnings DateNov 03, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est53.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PTGX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Protagonist Therapeutics, Inc.
    Weekly Stock ListVickers Stock Research, a subsidiary of Argus Research Group, tracks and analyzes insider trading and institutional ownership trends. Form 13-Fs are due 45 days after the end of calendar quarters, and have now come in from 2Q21. We like to review the 13Fs of the major activist investors, including Carl Icahn, Trian Fund Management, Jana Partners, and ValueAct Holdings, among others. Activist investing has evolved in recent years and is now less about generating a short-term return on an underpriced stock and more about achieving long-term returns through an active management/investor partnership. Here are some recent new purchases and key holdings of activist investors, according to Vickers.
    Rating
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
Advertisement
Advertisement